How infectious SARS-CoV-2 exploits two ER membrane proteins to promote infection
How infectious SARS-CoV-2 exploits two ER membrane proteins to promote infection
批准号:
10623348
负责人:
Billy Tsai
金额:
$38.18万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-17 至 2027-04-30
关键词:
2019-nCoVAntiviral AgentsBiologyCOVID-19COVID-19 pandemicCellsComplexCytosolDataDevelopmentDisease ProgressionDrug ModulationEndoplasmic ReticulumEndosomesFDA approvedGenetic TranscriptionGenomeGolgi ApparatusImpairmentInfectionIntegration Host FactorsLife Cycle StagesLinkMembraneMembrane FusionMembrane ProteinsMethodsMolecularNatureNonstructural ProteinOrganellesPathway interactionsProcessProtein SProteinsRNARoleSARS-CoV-2 infectionShapesSiteStructural ProteinStructureTestingTranslatingTranslationsVesicleViralViral GenomeViral ProteinsViral Structural ProteinsVirusVirus AssemblyVirus DiseasesVirus Replicationendosome membraneexperimental studygenomic RNAinsightloss of functionmultiple myeloma M Proteinparticlepolypeptidereceptor mediated endocytosisrecruitviral genomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
SARS-CoV-2 exploits the function of the endoplasmic reticulum (ER) to promote its
infection life cycle. Despite its strong reliance on the ER, the molecular basis by which
SARS-CoV-2 hijacks ER factors to promote defined steps of this life cycle remains
unclear. Using infectious SARS-CoV-2, we recently identified two ER membrane
proteins – RTN3 and SigmaR1 – as critical host factors that support virus infection. Our
findings further reveal that RTN3 plays a role in viral replication, while SigmaR1 exerts a
function in viral secretion. However, how SARS-CoV-2 exploits the activities of RTN3
and SigmaR1 to accomplish these two distinct tasks, in mechanistic terms, is completely
unknown. Accordingly, the objective of this application is to elucidate the molecular basis
by which these two ER membrane factors promote replication and secretion of SARS-
CoV-2. We believe these insights will not only illuminate the basic infection mechanism
of SARS-CoV-2, but given the continuing global COVID-19 pandemic, may lead to the
development of effective anti-virals to blunt the devastating impact of SARS-CoV-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel cytosolic chaperone complex in polyomavirus ER membrane transport
-
批准号:8850542
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2015
-
负责人:Billy Tsai
-
依托单位:
Mechanism of cholera toxin retro-translocation
-
批准号:8213508
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2010
-
负责人:Billy Tsai
-
依托单位:
Mechanism of cholera toxin retro-translocation
-
批准号:8603831
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2010
-
负责人:Billy Tsai
-
依托单位:
Mechanism of cholera toxin retro-translocation
-
批准号:8013922
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2010
-
负责人:Billy Tsai
-
依托单位:
Mechanism of cholera toxin retro-translocation
-
批准号:7882058
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2010
-
负责人:Billy Tsai
-
依托单位:
Mechanism of cholera toxin retro-translocation
-
批准号:8415539
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2010
-
负责人:Billy Tsai
-
依托单位:
Transport of polyomavirus across the ER membrane
-
批准号:7927845
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2009
-
负责人:Billy Tsai
-
依托单位:
Transport of polyomavirus across the ER membrane
-
批准号:7433890
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
How polyomaviruses penetrate the ER membrane
-
批准号:8580897
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
How polyomaviruses penetrate the ER membrane
-
批准号:8374100
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
How polyomaviruses penetrate the ER membrane
-
批准号:8766538
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
How polyomaviruses penetrate the ER membrane
-
批准号:8225518
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
Transport of polyomavirus across the ER membrane
-
批准号:7245084
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
How polyomaviruses penetrate the ER membrane
-
批准号:10091377
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
Transport of polyomavirus across the ER membrane
-
批准号:7849541
-
项目类别:
-
资助金额:$28.67万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
How polyomaviruses penetrate the ER membrane
-
批准号:9320149
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
Transport of polyomavirus across the ER membrane
-
批准号:7139024
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
Transport of polyomavirus across the ER membrane
-
批准号:7626048
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2006
-
负责人:Billy Tsai
-
依托单位:
海外基金